Probiodrug

Probiodrug is a biopharmaceutical company dedicated to the research and development of novel therapeutic solutions to treat people with Alzheimer’s Disease.

  • Accelerated bookbuild offering amounting to €14.9m.
  • Proceeds will be used to finance clinical development of their lead product and to support exploration and development of additional business opportunities.
  • Kempen & Co acted as Sole Global Coordinator and Joint Bookrunner in the transaction.
     
Disclaimer Kempen & Co Privacy statement Asset Management Privacy statement Merchant Banking Statement under the UK Modern Slavery Act Cookie statement & settings
Kempen & Co NV is part of Van Lanschot Kempen Van Lanschot